China Moves to Tighten Management, Use of Cancer Pharmaceuticals by Medical Institutions and Practitioners
Continuing to strengthen China’s oversight of the manufacture, import, and distribution of pharmaceuticals, the country’s health regulators in May published a series of measures medical institutions will be required to follow in prescribing and utilizing drugs to treat cancer. The measures released... Read More